Ann Hopkins
Has grant
Senior Lecturer
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Recent Grants
Grant: Close
Developing an innovative patient-centred xenograft model of multiple myeloma and its use in testing novel antagonists of JAM-A signalling.
Open Date: 2022-12-01
Close Date: 2025-12-01
Grant: Close
A multi-pronged translational approach towards testing a novel JAM-A inhibitor to reduce aggressive HER2-dependent breast cancer progression
Open Date: 2014-02-01
Close Date: 2019-12-01
Grant: Close
Understanding the mechanistic role and druggability of JAM-A, an emerging upstream regulator of breast cancer tumourigenic signalling, using in vitro and in vivo methodologies and a novel small molecule inhibitor
Open Date: 2014-01-01
Close Date: 2019-01-01
Grant: Close
In vivo testing of a novel JAM-A peptide for anti-tumour efficacy in a mouse mammary cancer model
Open Date: 2011-01-01
Close Date: 2012-06-30
Grant: Close
In vivo testing of a novel JAM-A peptide for anti-tumour efficacy in a mouse mammary cancer model
Open Date: 2011-01-01
Close Date: 2012-06-30
Articles (11)
Centrosome amplification (CA) is a prominent feature of human cancers linked to tumorigenesis in vivo. Here, we report mechanistic contributions of CA induction alone to tumour architecture and extracellular matrix (ECM) remodelling. CA induction in non-tumorigenic breast cells MCF10A causes cell migration and invasion, with underlying disruption of epithelial cell–cell junction integrity and dysregulation of expression and subcellular localisation of cell junction proteins. CA also elevates expression of integrin β-3, its binding partner fibronectin-1 and matrix metalloproteinase enzymes, promoting cell–ECM attachment, ECM degradation, and a migratory and invasive cell phenotype. Using a chicken embryo xenograft model for in vivo validation, we show that CA-induced (+CA) MCF10A cells invade into the chick mesodermal layer, with inflammatory cell infiltration and marked focal reactions between chorioallantoic membrane and cell graft. We also demonstrate a key role of small GTPase Rap-1 signalling through inhibition using GGTI-298, which blocked various CA-induced effects. These insights reveal that in normal cells, CA induction alone (without additional oncogenic alterations) is sufficient to confer early pro-tumorigenic changes within days, acting through Rap-1-dependent signalling to alter cell–cell contacts and ECM disruption.
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Collaborators (8)
Marian P. Brennan
RCSI University of Medicine and Health Sciences
Emer Bourke
-
Marc Devocelle
Associate Professor of Chemistry
Royal College of Surgeons in Ireland
Guannan Wang
Assistant Professor
Georgetown University
Arnold D.K. Hill
-
Hanne Jahns
-
kieran brennan
University College Dublin
Saraswati Sukumar
Professor
Johns Hopkins University School of Medicine
Make your next move.
Prepare your application
Review drafts before you send them.